Home Health & Hospice Weekly News Roundup

Our weekly list of news, reports, and information about home health and hospice care. Learn about new studies, trends, CMS regulations and more.


Bayada Transitions from For-Profit to Nonprofit to Save its Mission-Driven Culture


The founding CEO of Bayada Home Health Care, one of the nation’s largest home health companies with about $1.4 billion in annual revenues, was searching for a way to protect the values legacy of the company he founded by preventing its sale to profit-driven buyers. Baiada nixed the options of going public or private equity because he didn’t want to take on investors nor did he want to pass it on to his five children, telling the Courier Post in 2016 that “it’s hard to have a hereditary system that produces the competencies required to meet the demands of the public and the organization.” His solution: to go nonprofit, a move unprecedented in the home healthcare industry. Moving from sole-ownership to nonprofit by donating the entire company to a newly created charitable foundation ensures Bayada will remain family-guided, if not family-owned, but that it cannot go public or be sold. Baiada said it was the only way to ensure that the mission of the company, best summarized as “compassion, excellence, and reliability,” would continue to take precedence over profits.


Amedisys Reaches Analyst Target Price


In recent trading, shares of Amedisys, Inc. (Symbol: AMED) have crossed above the average analyst 12-month target price of $129.50, changing hands for $129.67/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, readjust their target price to a higher level. Analyst reaction may also depend on the fundamental business developments that may be responsible for driving the stock price higher - if things are looking up for the company, perhaps it is time for that target price to be raised.


Health Aides’ Low Wages Threaten Home Health Care, a Necessity for Millions


To say that home health aides’ work is demanding is an understatement. They help elderly and disabled individuals get out of bed, bathe, dress, use the bathroom, eat their meals, and take their medications. They act on behalf of family members who don’t have the time or resources to take their loved ones to the grocery store or a doctor’s appointment. Home health aides serve as the first line of defense by recognizing symptoms and behavioral changes and taking action to prevent costly and potentially dangerous hospitalizations. They make it possible for 14 million Americans to stay in their homes and out of expensive and impersonal institutional settings like hospitals and nursing homes. Along the way, they often become trusted members of the family. Performing this necessary and in-demand work takes a physical and emotional toll, yet these individuals do it with compassion day in and day out. So why do we treat home health aides as low-wage, low-value workers?


Home Healthcare Market to have Opportunities and High Demand by 2025


The global home healthcare market report provides the in-depth analysis of current trends affecting the global market to deliver the accurate forecasts. By comparing the historical data with several key market dynamics, our predictors can make extremely sharp estimates. This report also comprises a thorough analysis of the market segmentation by service, product, application, software, and geographical region. Growth, trends, and opportunities are emphasized coupled with the global market share as well as their estimation in the market.